Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 104 M130 M87 M114 M105 M 436 M Research & development ————— — Operating income -8 M-1.01 B-1.32 B-750 M-22 M -3.1 B Non-Operating Income, Total -12 M-66 M69 M37 M-4 M 36 M Interest expense, net of interest capitalized 22 M22 M24 M24 M24 M 94 M Non-Operating Income, excl. Interest Expenses -45 M-95 M37 M13 M-29 M -74 M Unusual income/expense 11 M7 M8 M01 M 16 M Pretax income -20 M-1.08 B-1.25 B-713 M-26 M -3.07 B Equity in earnings ————— — Taxes -3 M-3 M-198 M220 M-7 M 12 M Non-controlling/minority interest 0-1 M-1 M00 -2 M After tax other income/expense —-11 M0-4 M-4 M -19 M Net income before discontinued operations -17 M-1.07 B-1.05 B-933 M-19 M -3.08 B Discontinued operations -8 M-1 M-13 M1 M0 -13 M Net income -25 M-1.07 B-1.07 B-932 M-19 M -3.09 B Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders -25 M-1.07 B-1.07 B-932 M-19 M -3.09 B Basic earnings per share (Basic EPS) -1-40.6-40.4-35.4-0.8 -117.2 Diluted earnings per share (Diluted EPS) -1-40.6-40.4-35.4-0.8 -117.2 Average basic shares outstanding 26.61 M26.42 M26.33 M26.38 M26.24 M — Diluted shares outstanding 26.61 M26.42 M26.33 M26.38 M26.24 M — EBITDA 119 M-882 M-1.19 B-405 M113 M -2.37 B EBIT 18 M-983 M-1.29 B-720 M9 M -2.99 B Cost of revenue 351 M325 M327 M383 M347 M 1.38 B Other cost of goods sold 351 M325 M327 M383 M347 M 1.38 B Depreciation & amortization (cash flow) 101 M101 M103 M315 M104 M 623 M